April 12, 2021 12:00 PM
Newmark announces the $105 million sale of One Investors Way, a biomanufacturing campus redevelopment opportunity located in Norwood, Massachusetts. Newmark Co-Head of U.S. Capital Markets Robert Griffin, Vice Chairman Edward Maher, Executive Managing Director Matthew Pullen and Managing Director Samantha Hallowell of the firm’s Boston Capital Markets Group represented the seller, U.S. Realty Advisors and Bain Capital Real Estate, and procured the buyer. Senior Financial Analyst Will Sleeper provided financial analysis support.
Set on a ±54-acre site, One Investors Way includes an existing 236,566-square-foot office building that is primed for repositioning coupled with excess land that is well positioned for new construction.
“One Investors Way presents an exceptional opportunity to capitalize on the Greater Boston market’s insatiable demand for biomanufacturing inventory,” said Matthew. “The property benefits from prime positioning just 20 miles from Cambridge along suburban Boston’s coveted Route 128/Interstate 95 corridor.”
One Investors Way is surrounded by a biomanufacturing-anchored campus that serves as home to a two-building flagship for biotechnology company Moderna and a 260-unit apartment community. Nearby amenities include University Station in Westwood and Legacy Place in Dedham.
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate services, with a comprehensive suite of investor/owner and occupier services and products. Our integrated platform seamlessly powers every phase of owning or occupying a property. Our services are tailored to every type of client, from owners to occupiers, investors to founders, growing startups to leading companies. Harnessing the power of data, technology, and industry expertise, we bring ingenuity to every exchange, and imagination to every space. Together with London-based partner Knight Frank and independently owned offices, our 18,800 professionals operate from approximately 500 offices around the world, delivering a global perspective and a nimble approach. In 2020, Newmark generated revenues in excess of $1.9 billion. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.